Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

187 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosis.
Wijsenbeek M, Swigris JJ, Inoue Y, Kreuter M, Maher TM, Suda T, Baldwin M, Mueller H, Rohr KB, Flaherty KR; INBUILD Trial Investigators. Wijsenbeek M, et al. Eur Respir J. 2024 Feb 1;63(2):2300752. doi: 10.1183/13993003.00752-2023. Print 2024 Feb. Eur Respir J. 2024. PMID: 38135442 Free PMC article. Clinical Trial.
Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis.
Judson MA, Baughman RP, Costabel U, Drent M, Gibson KF, Raghu G, Shigemitsu H, Barney JB, Culver DA, Hamzeh NY, Wijsenbeek MS, Albera C, Huizar I, Agarwal P, Brodmerkel C, Watt R, Barnathan ES. Judson MA, et al. Among authors: wijsenbeek ms. Eur Respir J. 2014 Nov;44(5):1296-307. doi: 10.1183/09031936.00000914. Epub 2014 Jul 17. Eur Respir J. 2014. PMID: 25034562 Free article. Clinical Trial.
Challenges in the classification of fibrotic ILD.
Bendstrup E, Maher TM, Manali ED, Wijsenbeek M. Bendstrup E, et al. Among authors: wijsenbeek m. Sarcoidosis Vasc Diffuse Lung Dis. 2015 Aug 3;32 Suppl 1:4-9. Sarcoidosis Vasc Diffuse Lung Dis. 2015. PMID: 26237436 Review.
Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy.
van den Blink B, Dillingh MR, Ginns LC, Morrison LD, Moerland M, Wijsenbeek M, Trehu EG, Bartholmai BJ, Burggraaf J. van den Blink B, et al. Among authors: wijsenbeek m. Eur Respir J. 2016 Mar;47(3):889-97. doi: 10.1183/13993003.00850-2015. Epub 2016 Feb 11. Eur Respir J. 2016. PMID: 26869678 Free article. Clinical Trial.
Medical Therapy in Idiopathic Pulmonary Fibrosis.
Antoniou KM, Wuyts W, Wijsenbeek M, Wells AU. Antoniou KM, et al. Among authors: wijsenbeek m. Semin Respir Crit Care Med. 2016 Jun;37(3):368-77. doi: 10.1055/s-0036-1582010. Epub 2016 May 27. Semin Respir Crit Care Med. 2016. PMID: 27231861 Review.
Cough in idiopathic pulmonary fibrosis.
van Manen MJ, Birring SS, Vancheri C, Cottin V, Renzoni EA, Russell AM, Wijsenbeek MS. van Manen MJ, et al. Eur Respir Rev. 2016 Sep;25(141):278-86. doi: 10.1183/16000617.0090-2015. Eur Respir Rev. 2016. PMID: 27581827 Free PMC article. Review.
187 results